ATALANTA SOSNOFF CAPITAL, LLC

Position in JNJ — Johnson & Johnson

CIK 700529 New York, NY

Position in JNJ

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$556,702

+$284,367 QoQ

Shares Held

2,192

+24.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#3,590

of 4,664 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

ATALANTA SOSNOFF CAPITAL, LLC holds $180,479,355 across 9 Drug Manufacturers - General names. JNJ ranks #5 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	77,995	$93,549,550
2	MRK	Merck & Co., Inc.	642,053	$82,503,810
3	ABBV	AbbVie Inc.	7,988	$2,010,099
4	PFE	Pfizer Inc	23,858	$574,500
5	JNJ	Johnson & Johnson This page	2,192	$556,702
6	BMY	Bristol Myers Squibb Co	5,696	$328,203
7	GSK	GSK plc	6,144	$322,068
8	GILD	Gilead Sciences, Inc.	2,548	$321,914

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$556,702	2,192	+24.8%	Shares	Sole	2026-08-12
2023-03-31	$272,335	1,757	-99.4%	Shares	Defined	2023-05-11
2022-12-31	$48,142,776	272,532	-32.0%	Shares	Sole	2023-05-22
2022-09-30	$65,508,830	401,009	-10.5%	Shares	Sole	2022-10-12
2022-06-30	$79,494,125	447,829	-1.3%	Shares	Sole	2022-07-14
2022-03-31	$80,404,642	453,674	-9.4%	Shares	Sole	2022-04-11
2021-12-31	$85,698,029	500,953	-8.4%	Shares	Sole	2022-01-25
2021-09-30	$88,293,988	546,712	-0.4%	Shares	Sole	2021-10-14
2021-06-30	$90,462,522	549,123	+8.0%	Shares	Sole	2021-07-13
2021-03-31	$83,538,775	508,298	-0.5%	Shares	Sole	2021-04-20
2020-12-31	$80,429,205	511,051	-5.4%	Shares	Sole	2021-01-14
2020-09-30	$80,414,404	540,129	+0.8%	Shares	Sole	2020-10-14
2020-06-30	$75,350,115	535,804	+82.6%	Shares	Sole	2020-07-21
2020-03-31	$38,471,705	293,386	—	Shares	Sole	2020-04-16
No filing history on record for this holder in this stock.